The study aims to test the safety of Repetitive Magnetic Stimulation (RMS) treatment for dry eye disease. Patients are asked to undergo a one-time treatment with Epitech Ocular Magnetic Stimulation Device on one eye in the first stage and both eyes sequentially in the second stage of the study. Changes are monitored for over a study period of 3 months.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
29
First stage: Patients will be asked to undergo a one-time treatment with Epitech Corneal Magnetic Stimulation Device on one eye. The worst eye will be treated; if both eyes are equal, the right eye will be treated. Second stage: will be treated on both eyes, applying treatment to both eyes sequentially during the same visit.
E. Wolfson Medical Center
Holon, Israel
Hadassah Medical Center
Jerusalem, Israel
Shaare Zedek Medical Center (SZMC)
Jerusalem, Israel
Best Corrected Visual Acuity (BCVA)
Time frame: 3 mounth
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.